Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 597

recruiting
3 975
countries
28
conditions
2 109

10 403 trials match your criteria

Study on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Neoplasm

Not recruiting

Study on NECVAX-NEO1 with PD-1/PD-L1 Inhibitors for Patients with Advanced Solid Tumors

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Cough

Not recruiting

Study on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Cutaneous sarcoidosis

Not recruiting

Study on Sirolimus for Adults with Facial Skin Sarcoidosis: Evaluating Treatment for Moderate to Severe Cases

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Study of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Hidradenitis

Not recruiting

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years

Cluster headache

Not recruiting

Study on Repeated Corticosteroid Injections with Methylprednisolone Acetate and Sodium Chloride for Patients with Chronic Cluster Headache

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
Countries:GermanyGermany
  • Participants:0–17 years

Hypercholesterolaemia

Not recruiting

Study on MK-0616, Ezetimibe, and Bempedoic Acid for Adults with High Cholesterol

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Uveal melanoma

Not recruiting

Study of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.